100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Practice questions Tumor Immunology $4.87   Add to cart

Other

Practice questions Tumor Immunology

 6 views  0 purchase
  • Course
  • Institution

Here are 25 practice questions based on my lecture notes. These questions test if you fully understand the study material.

Preview 2 out of 5  pages

  • October 24, 2024
  • 5
  • 2022/2023
  • Other
  • Unknown
avatar-seller
Practice questions:

Advanced Tumor Immunology Concepts

1. How do tumors leverage the immunosuppressive functions of regulatory T-cells (T-reg) and
myeloid-derived suppressor cells (MDSCs) to evade immune surveillance, and what are the
molecular mechanisms involved?
2. Describe the process of cross-dressing in dendritic cells (DCs) and explain its implications in
tumor immunology.
3. Explain the mechanisms by which tumors reduce MHC-I expression and the role of NK cells in
compensating for this immune evasion strategy.

Tumor Evasion and Immune Editing

4. How does the concept of immune editing explain the transition from tumor elimination to
equilibrium and eventually to immune escape? Provide examples of immune evasion
mechanisms that tumors develop over time.
5. Discuss the role of co-stimulatory and inhibitory signals in T-cell activation and how tumors
exploit these pathways to induce T-cell anergy.
6. How do tumors manipulate macrophages to favor an immunosuppressive (M2) phenotype,
and what are the consequences of this shift for tumor progression?

Immunotherapy and Tumor Vaccines

7. What is the rationale behind using checkpoint inhibitors like anti-PD-1 and anti-CTLA-4 in
combination, and what are the limitations of this approach?
8. Explain the concept of autologous dendritic cell (DC) vaccination in cancer therapy, including
the key challenges associated with this approach.
9. In CAR-T cell therapy, what are the advantages and challenges of targeting solid tumors
compared to hematological malignancies?

Advanced Tumor Antigen Recognition

10. Differentiate between tumor-specific antigens (TSAs) and tumor-associated antigens (TAAs) in
the context of cancer immunotherapy. Why are TSAs considered more ideal targets?
11. Describe the role of neoantigens in the success of immune checkpoint blockade therapies.
12. How does cross-presentation by dendritic cells contribute to the activation of cytotoxic T-
lymphocytes (CTLs) in the tumor microenvironment?

Glycosylation and Tumor Immunology

13. What is the role of aberrant glycosylation in tumor immune evasion, and how do lectins such
as Siglecs contribute to this process?
14. How can targeting tumor-associated glycan structures be used as a therapeutic strategy in
cancer immunotherapy?

Myeloid-Derived Suppressor Cells (MDSCs)

15. Explain the transcriptional regulation of MDSCs in the tumor microenvironment and how it
leads to immune suppression.
16. How do MDSCs contribute to tumor metastasis, and what are the mechanisms involved in
this process?

, Virotherapy and Oncolytic Viruses

17. What mechanisms allow oncolytic viruses to selectively replicate in tumor cells, and how
does this strategy enhance anti-tumor immunity?
18. How can combining oncolytic virotherapy with immune checkpoint inhibitors enhance
therapeutic outcomes in cancer patients?

Advanced Diagnostic Techniques

19. How does liquid biopsy compare to traditional tissue biopsy in terms of identifying prognostic
and predictive biomarkers for cancer?
20. Discuss the advantages and limitations of using single-cell RNA sequencing in tumor
immunology research.

Immune Modulation in Cancer Therapy

21. How does radiotherapy-induced immunogenic cell death enhance the efficacy of immune
checkpoint blockade?
22. Explain the STING (Stimulator of Interferon Genes) pathway and its role in the anti-tumor
immune response following DNA damage in cancer cells.

Advanced Immunotherapy Strategies

23. How does the tumor microenvironment influence the efficacy of CAR-T cell therapy, and what
strategies are being developed to overcome these challenges?
24. What role does the gut microbiome play in modulating the response to cancer
immunotherapy, and how could microbiome manipulation be used as a therapeutic strategy?
25. How does the combination of bispecific T-cell engagers (BiTEs) and oncolytic viruses enhance
tumor cell targeting and destruction?

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller sweerstand. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $4.87. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

85443 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$4.87
  • (0)
  Add to cart